Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'

On Sunday, President Donald Trump vowed to slash prescription drug prices through a sweeping executive order.

What Happened: Trump took to Truth Social and announced plans to sign a new executive order. Under what he called a "most favored nation" pricing policy, the President said the executive order will ensure that "the United States will pay the same price as the Nation that pays the lowest price anywhere in the World."

Screenshot From President Donald Trump’s Truth Social Account

He added that prescription drug prices would drop "almost immediately, by 30% to 80%," and called the move "one of the most consequential Executive Orders in our Country's history."

In response, a user on X, formerly Twitter, expressed skepticism, saying, "It would be nice if Trump’s super important post about drug prices was really achievable. I think all Democrats would agree… But like most things Trump brags about, they are pie-in-the-sky promises that can’t and won’t actually materialize."

See Also:  Elizabeth Warren Says, ‘If Trump Illegally Fires Fed Chair Powell, He'll Crash Our Markets, Cause More Economic Pain To American Families'

That's where billionaire entrepreneur and Cost Plus Drugs founder Mark Cuban stepped in. Cuban acknowledged the ambition of Trump's plan but highlighted a more attainable path forward.

"I don't know if he can force the price, but he can force transparency, and that will help," Cuban wrote.

Why It's Important: Last month, Trump issued a multi-part executive order targeting drug pricing transparency and Medicare cost reduction.

Earlier this month, he signed another executive order directing the Food and Drug Administration to expedite approvals for domestic pharmaceutical manufacturing facilities.

The Invesco Pharmaceuticals ETF PJP and iShares U.S. Pharmaceuticals ETF IHE rose 2.61% and 2.81%, respectively, over the past month.

Price Action: In after-hours trading, Novo Nordisk A/S NVO was up 0.20%, while Eli Lilly and Co. LLY and Pfizer Inc. PFE increased by 0.32% and 0.13%, respectively. Johnson & Johnson JNJ also saw a modest gain of 0.12%, according to data from Benzinga Pro.

Photo Courtesy: PeopleImages.com – Yuri A On Shutterstock.com

Read Next:

• Dogecoin Jumps 7%, Shiba Inu Up 4%: Is A Major Meme Rally Brewing?

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.